Latest / Stock Movers / Pepsi Reports; AstraZeneca and Levi Strauss Fall
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios, podcasts, radio news, The.
- 0:08Speaker 2: Stock Movers Report, your roundup of companies making moves in
- 0:12Speaker 2: the stock market, harnessing the power of Bloomberg Data.
- 0:16Speaker 1: Let's take a look at some stocks on the move today.
- 0:19Speaker 1: I'm Karen Moscow. We're joined by Bloomberg's Dan Curtis. Dan.
- 0:22Speaker 1: Good morning. Hey. We want to start things off with
- 0:25Speaker 1: some earnings from Pepsi that cross this morning. What did
- 0:28Speaker 1: we hear? So?
- 0:29Speaker 3: We heard that organic sales growth in North America snacks
- 0:32Speaker 3: business missed estimates as lower prices cut into revenue. Shares
- 0:37Speaker 3: are currently on their back foot, down about three quarters
- 0:40Speaker 3: of a percent under ticker PEP. Second quarter revenue and
- 0:43Speaker 3: adjusted earnings came in just above market expectations, and that
- 0:47Speaker 3: was boosted by international sales, but lots of focus on
- 0:50Speaker 3: the North American business. There was a two percent decline
- 0:53Speaker 3: in that food business. Pepsi's been rolling out snacks with
- 0:56Speaker 3: higher protein and fiber amidshifts and consumer preferences to try
- 0:59Speaker 3: and meet them there, and they had been working to
- 1:02Speaker 3: boost sales in that region. They had seen signs of
- 1:05Speaker 3: an initial rebound earlier this year after cutting prices. We
- 1:08Speaker 3: had a lot of stories earlier this year about you know,
- 1:10Speaker 3: seven dollars per bag of Doritos for a large bag
- 1:14Speaker 3: of Dorito's PEPSI has been working to roll that out.
- 1:16Speaker 3: Those price cuts, though, are eating into that bottom line.
- 1:19Speaker 1: Just a bit eating, so to speak. How will I
- 1:21Speaker 1: set back for AstraZeneca that's weighing this morning as well.
- 1:25Speaker 3: Yeah, so it's a very rare setback for the pharma
- 1:28Speaker 3: company in a new heart drug. So it's said that
- 1:32Speaker 3: a drug it's developing with Ionis pharmaceutical failed to help
- 1:35Speaker 3: prevent heart problems in patients with the rare disease. That
- 1:38Speaker 3: has shares of Astroseneka down eight percent on the ADRs.
- 1:41Speaker 3: Ionis Pharmaceuticals take our ions Is down twenty percent in
- 1:46Speaker 3: pre market. The drug has already been improved for patients
- 1:49Speaker 3: with certain protein folding issues. However, Astra had set a
- 1:53Speaker 3: five billion dollar sales target for this drug, and so
- 1:56Speaker 3: this this stumbling block is going to make it harder
- 1:59Speaker 3: for the company to reach that deal. Jeffries is also
- 2:02Speaker 3: pointing out that Astra typically designs its trials so that
- 2:06Speaker 3: they are mostly watertight, so some of this reaction might
- 2:08Speaker 3: just be more than a loss of potential revenue, but
- 2:10Speaker 3: also a perceived slip incredibility.
- 2:13Speaker 1: Well, Levi Strauss is also on your radar this morning.
- 2:16Speaker 1: What's happening with them.
- 2:17Speaker 3: It's raised its full yar guidance for a second straight
- 2:20Speaker 3: quarter on top of a second quarter top and bottom
- 2:22Speaker 3: line beat, but that is not enough for markets. Those
- 2:25Speaker 3: shares are down six percent in the pre market. The
- 2:29Speaker 3: net revenue growth outlook of up to seven and a
- 2:32Speaker 3: half percent, but some analysts say the hike is due
- 2:35Speaker 3: to first half out performance, so performance already in the
- 2:38Speaker 3: bag and not second half optimism which might get them
- 2:41Speaker 3: to buy the stock this morning. And this is coming
- 2:44Speaker 3: as the San Francis Francisco company has turned to selling
- 2:47Speaker 3: more tops and jackets, which has been a winning strategy
- 2:50Speaker 3: for them. It's also prioritizing its own business, its own platforms,
- 2:54Speaker 3: which are generating over half of sales. So there is
- 2:56Speaker 3: some optimism going into this, but not quite enough of
- 2:59Speaker 3: a lift for Wall Street this morning.
- 3:01Speaker 1: And we have an analyst call on Salesforce.
- 3:04Speaker 3: That's right, So keeping my eye on the software sector
- 3:08Speaker 3: very closely. And we have salesforce which was cut too
- 3:11Speaker 3: sector weight from equal from overweight at Key Bank. Those
- 3:14Speaker 3: shares are down about four percent in pre market, and
- 3:17Speaker 3: we are seeing general software weakness in the market this morning.
- 3:20Speaker 3: This has been, you know, amid a share slump, so
- 3:23Speaker 3: shares are trading at less than half the price they
- 3:25Speaker 3: were at eighteen months ago, amid this whole SaaS pocalypse
- 3:28Speaker 3: trade software companies hit by concern over AI's threat. So
- 3:32Speaker 3: we're seeing some software names weaker in the pre market,
- 3:35Speaker 3: standing out salesforce on that downgrade.
- 3:37Speaker 1: And just quickly, I know, with oil and gas prices higher,
- 3:40Speaker 1: I've been going to Costco to fill up. Is that
- 3:42Speaker 1: showing up in their sales?
- 3:44Speaker 3: Not quite so. Costco shares are down one percent in
- 3:47Speaker 3: the pre market, so total comparable sales came out at
- 3:50Speaker 3: nearly nine percent, but the estimate was nearly ten percent.
- 3:53Speaker 3: So while there has been that search, it's not quite
- 3:56Speaker 3: what the market was looking for, and some of this
- 3:58Speaker 3: was already baked into the price. So if you take
- 4:00Speaker 3: a look at shares of Costco, those shares are up
- 4:02Speaker 3: ten percent year to date. Compare that to a company
- 4:04Speaker 3: like Walmart. Walmart's shares are only up about one and
- 4:07Speaker 3: a half percent. So Costco had been out performing into
- 4:10Speaker 3: this on some strong on some strong momentum. We're pulling
- 4:13Speaker 3: back a little bit from that in the pre market,
- 4:15Speaker 3: down one percent.
- 4:17Speaker 2: This stock Movers report from Bloomberg Radio. Check back with
- 4:21Speaker 2: us throughout the day for the latest roundup of companies
- 4:23Speaker 2: making news on Wall Street and for the latest market
- 4:26Speaker 2: moving headlines. Listen to Bloomberg Radio Live, catch us on YouTube,
- 4:31Speaker 2: Bloomberg dot com, and on Applecarplay and Android Auto with
- 4:35Speaker 2: the Bloomberg Business app.